| [1] |
赵航，陆伦根．继发性硬化性胆管炎临床研究进展[J]．中华消化杂志，2012，32(6):430-432.
|
| [2] |
Abdolian R, Heathcrte EJ. Sclerosing cholangitis: a focus on secondary causes[J]. Hepatology, 2006, 44(5):1063-1074.
|
| [3] |
Gossard AA, Angulo P, Lindor KD. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis[J]. Am J Gastroenterol, 2005, 100(6):1330-1333.
|
| [4] |
Scheppach W, Druge G, Wittenberg G, et al. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases[J]. Crit Care Med, 2001, 29(2):438-441.
|
| [5] |
Lin T, Qu K, Xu X, et al. Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience[J]. Front Med, 2014, 8(1):118-126.
|
| [6] |
何振平．重危患者ICU治疗的肝损伤——继发性硬化性胆管炎[J]．国际外科学杂志，2009，36(2):73-75.
|
| [7] |
Leonhardt S, Veltzke-Schlieker W, Adler A, et al. Secondary sclerosing cholangitis in criticallyⅢ patients: clinical presentation, cholangiographic features, natural history, and outcome: a series of 16 cases[J]. Medicine, 2015, 94(49):e2188.
|
| [8] |
Bansal V, Schuchert VD. Jaundice in the intensive care unit[J]. Surg Clin North Am, 2006, 86(6):1495-1502.
|
| [9] |
Kwon ON, Cho SH, Park CK, et al. Biliary cast formation with sclerosing cholangitis in critically ill patient: case report and literature review[J]. Korean J Radiol, 2012, 13(3):358-362.
|
| [10] |
Weber C, Kuhlencordt R, Grotelueschen R, et al. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis[J]. Endoscopy, 2008, 40(9):739-745.
|
| [11] |
Esposito I, Kubisova A, Stiehl A, et al. Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis[J]. Virchows Arch, 2008, 453(4):339-345.
|
| [12] |
Wagner M, Zollner G, Trauner M. Ischemia and cholestasis: more than (just) the bile ducts![J]. Transplantation, 2008, 85(8):1083-1085.
|
| [13] |
Gelbmann CM, Rümmele P, Wimmer M, et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients[J]. Am J Gastroenterol, 2007, 102(6):1221-1229.
|
| [14] |
Benninger J, Grobholz R, Oeztuerk Y, et al. Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms[J]. World J Gastroenterol, 2005, 11(27):4199-4205.
|
| [15] |
Leonhardt S, Veltzke-Schlieker W, Adler A, et al. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients[J]. Crit Care, 2015(19):131.
|
| [16] |
Beuers U, Hohenester S, de Buy Wenniger LJ, et al. The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies[J]. Hepatology, 2010, 52(4):1489-1496.
|
| [17] |
Popov Y, Patsenker E, Fickert P, et al. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes[J]. J Hepatol, 2005, 43(6):1045-1054.
|
| [18] |
Diao L, Li N, Brayman TG, et al. Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-alpha, IL-6, and IL-1 beta[J]. J Biol Chem, 2010, 285(41):31185-31192.
|
| [19] |
Kulaksiz H, Heuberger D, Engler S, et al. Poor outcome in progressive sclerosing cholangitis after septic shock[J]. Endoscopy, 2008, 40(3):214-218.
|
| [20] |
Jaeger C, Mayer G, Henrich R, et al. Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up[J]. Endoscopy, 2006, 38(7):730-734.
|
| [21] |
Katsinelos P, Kountouras J, Chatzimavroudis G, et al. Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient[J].World J Gastroenterol, 2008, 14(33):5223–5225.
|
| [22] |
Kirehner GI, Scherer MN, Obed A, et al. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation[J]. Scand J Gastroenterol, 2011, 46(4):471-478.
|